Logo image of RIBT

RICEBRAN TECHNOLOGIES (RIBT) Stock Fundamental Analysis

NASDAQ:RIBT - Nasdaq - US7628313030 - Common Stock - Currency: USD

0.35  -0.01 (-1.69%)

After market: 0.3675 +0.02 (+5%)

Fundamental Rating

1

RIBT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 90 industry peers in the Food Products industry. RIBT has a bad profitability rating. Also its financial health evaluation is rather negative. RIBT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year RIBT has reported negative net income.
In the past year RIBT has reported a negative cash flow from operations.
RIBT had negative earnings in each of the past 5 years.
RIBT had a negative operating cash flow in each of the past 5 years.
RIBT Yearly Net Income VS EBIT VS OCF VS FCFRIBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -5M -10M -15M

1.2 Ratios

The Return On Assets of RIBT (-141.05%) is worse than 95.70% of its industry peers.
RIBT has a Return On Equity of -1786.67%. This is amonst the worse of the industry: RIBT underperforms 94.62% of its industry peers.
Industry RankSector Rank
ROA -141.05%
ROE -1786.67%
ROIC N/A
ROA(3y)-30.33%
ROA(5y)-30.36%
ROE(3y)-53.15%
ROE(5y)-47.52%
ROIC(3y)N/A
ROIC(5y)N/A
RIBT Yearly ROA, ROE, ROICRIBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 2K 4K 6K 8K

1.3 Margins

RIBT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RIBT Yearly Profit, Operating, Gross MarginsRIBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 -20 -40 -60

More info and screens

0

2. Health

2.1 Basic Checks

RIBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RIBT has been increased compared to 1 year ago.
The debt/assets ratio for RIBT is higher compared to a year ago.
RIBT Yearly Shares OutstandingRIBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M
RIBT Yearly Total Debt VS Total AssetsRIBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

2.2 Solvency

RIBT has an Altman-Z score of -39.85. This is a bad value and indicates that RIBT is not financially healthy and even has some risk of bankruptcy.
RIBT has a worse Altman-Z score (-39.85) than 97.85% of its industry peers.
A Debt/Equity ratio of 3.78 is on the high side and indicates that RIBT has dependencies on debt financing.
The Debt to Equity ratio of RIBT (3.78) is worse than 93.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.78
Debt/FCF N/A
Altman-Z -39.85
ROIC/WACCN/A
WACC7.79%
RIBT Yearly LT Debt VS Equity VS FCFRIBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M 30M

2.3 Liquidity

RIBT has a Current Ratio of 0.51. This is a bad value and indicates that RIBT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.51, RIBT is doing worse than 94.62% of the companies in the same industry.
A Quick Ratio of 0.45 indicates that RIBT may have some problems paying its short term obligations.
With a Quick ratio value of 0.45, RIBT is not doing good in the industry: 84.95% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.45
RIBT Yearly Current Assets VS Current LiabilitesRIBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M

More info and screens

3

3. Growth

3.1 Past

RIBT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.77%.
The Revenue has grown by 19.84% in the past year. This is quite good.
The Revenue has been growing by 25.52% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-8.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-212.24%
Revenue 1Y (TTM)19.84%
Revenue growth 3Y20.63%
Revenue growth 5Y25.52%
Sales Q2Q%-4.71%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RIBT Yearly Revenue VS EstimatesRIBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
RIBT Yearly EPS VS EstimatesRIBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 -2 -4 -6 -8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

RIBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RIBT Price Earnings VS Forward Price EarningsRIBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RIBT Per share dataRIBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RIBT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RICEBRAN TECHNOLOGIES

NASDAQ:RIBT (11/7/2023, 8:20:17 PM)

After market: 0.3675 +0.02 (+5%)

0.35

-0.01 (-1.69%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-09 2023-11-09/amc
Earnings (Next)03-14 2024-03-14/amc
Inst Owners0.04%
Inst Owner Change0%
Ins Owners96.78%
Ins Owner Change0%
Market Cap2.31M
Analysts43.33
Price Target4.59 (1211.43%)
Short Float %0%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B 2.57
P/tB 3.86
EV/EBITDA N/A
EPS(TTM)-2.48
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS4.99
BVpS0.14
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -141.05%
ROE -1786.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-30.33%
ROA(5y)-30.36%
ROE(3y)-53.15%
ROE(5y)-47.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.89
Health
Industry RankSector Rank
Debt/Equity 3.78
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 27.88%
Cap/Sales 1.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.45
Altman-Z -39.85
F-Score3
WACC7.79%
ROIC/WACCN/A
Cap/Depr(3y)41.77%
Cap/Depr(5y)153.21%
Cap/Sales(3y)3.49%
Cap/Sales(5y)10.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-212.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.84%
Revenue growth 3Y20.63%
Revenue growth 5Y25.52%
Sales Q2Q%-4.71%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25.33%
OCF growth 3YN/A
OCF growth 5YN/A